Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES |
|
|
Latest News & Press Releases |
|
|
|
|
UK Approves Pfizer COVID-19 Vaccine: Expect A Next Week Roll-Out.
In a historic occurrence which has taken the world by storm, the UK Government has officially approved the usage of Pfizer's coronavirus vaccine.
|
| |
| |
|
Saudi Pharma in talks with Germanys CureVac for coronavirus shot.
Saudi Pharmaceutical Industries and Medical Appliances Corp. have signed a non binding memorandum of understanding with German biotech company CureVac NV to provide..
|
|
|
|
| | |
| |
|
|
|
FDA Grants FTD for Remestemcel-L in the Treatment of Acute Respiratory Distress Syndrome Due to COVID-19.
Mesoblast announced that the US FDA has granted Fast Track designation for remestemcel L in the treatment of acute respiratory distress syndrome..
|
|
| | | | |
| |
|
Patent Protection Lift-off For COVID-19 Vaccines; Not a Bright Choice
The world of Pharmaceuticals is caught in the web of who brings out the vaccine and when scenario. The darkest hours that the world has been a witness to are from the last 10 months. However, every day...
|
|
|
|
|
| |
|
|
|
How vaccines can be stored and administered safely.
Until the vaccine against Covid-19 becomes available, hygiene rules and concepts should help to ensure that as few people as possible become infected. In addition, it is important that the body...
|
|
| |
|
Envirotainer broadens its partnership with Unilode to support global COVID-19 vaccine distribution.
Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, broadens its existing partnership with Unilode...
|
|
|
|
| | |
|
| |
|
|
|
AstraZeneca Says Forxiga Approved In Japan For Heart Failure.
AstraZeneca's Forxiga has been approved in Japan for the treatment of patients with chronic heart failure who are receiving standard of care.
|
|
| | | | |
| |
|
Bayer establishes Cell and Gene Therapy Platform to accelerate pharmaceutical innovation.
Bayer AG announced the launch of a Cell and Gene Therapy Platform within its Pharmaceuticals division. Through this strategic platform, the company...
|
|
|
| | | | |
| |
|
|
|
BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years.
BD announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity and technology for pre fillable...
|
|
|